Literature DB >> 26960906

The Current Status of Oral Contraceptives: Progress and Recent Innovations.

Alexandra Golobof1, Jessica Kiley1.   

Abstract

Millions of women in the United States and abroad use oral contraceptive pills. These popular contraceptives are the most common reversible birth control method in the United States, and a wide variety of pills are available for prescription. Oral contraceptives provide safe and effective protection against pregnancy and offer several noncontraceptive benefits. Over the years, advances in the laboratory and knowledge gained through epidemiologic data promoted the development of new contraceptive preparations. Generations of oral contraceptives emerged over time, containing lower doses of estrogens and new and novel progestins. The current review discusses the clinical characteristics of oral contraceptives, with emphasis on basic pharmacology and the evolution of various contraceptive formulations and regimens. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26960906     DOI: 10.1055/s-0036-1572546

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  12 in total

1.  Circulating sex steroids and bladder pain sensitivity in dysmenorrhea.

Authors:  Kevin M Hellman; Folabomi A Oladosu; Ellen F Garrison; Genevieve E Roth; Katlyn E Dillane; Frank F Tu
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

2.  Associations of Oral Contraceptives with Mammographic Breast Density in Premenopausal Women.

Authors:  Lusine Yaghjyan; Carmen Smotherman; John Heine; Graham A Colditz; Bernard Rosner; Rulla M Tamimi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-12-03       Impact factor: 4.090

3.  Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles.

Authors:  Yao Lu; Yichao Niu; Yuan Wang; Yaqiong He; Ying Ding; Xinyuan Lu; Bing Xu; Steven R Lindheim; Yun Sun
Journal:  Front Physiol       Date:  2021-03-11       Impact factor: 4.566

4.  Oral Contraceptive Use and Risks of Cancer in the NIH-AARP Diet and Health Study.

Authors:  Kara A Michels; Louise A Brinton; Ruth M Pfeiffer; Britton Trabert
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

5.  Oral contraceptives cause evolutionarily novel increases in hormone exposure: A risk factor for breast cancer.

Authors:  Jennie L Lovett; Margo A Chima; Juliana K Wexler; Kendall J Arslanian; Andrea B Friedman; Chantal B Yousif; Beverly I Strassmann
Journal:  Evol Med Public Health       Date:  2017-06-05

6.  An Update on Contraception in Polycystic Ovary Syndrome.

Authors:  Seda Hanife Oguz; Bulent Okan Yildiz
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-15

7.  Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.

Authors:  Kara A Michels; Ruth M Pfeiffer; Louise A Brinton; Britton Trabert
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777

8.  Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.

Authors:  Sebastian Simu; Iasmina Marcovici; Amadeus Dobrescu; Daniel Malita; Cristina Adriana Dehelean; Dorina Coricovac; Flavius Olaru; George Andrei Draghici; Dan Navolan
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

9.  Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age.

Authors:  Radosław Słopień; Ewa Milewska; Piotr Rynio; Błażej Męczekalski
Journal:  Prz Menopauzalny       Date:  2018-04-11

10.  Oral contraceptive use by formulation and endometrial cancer risk among women born in 1947-1964: The Nurses' Health Study II, a prospective cohort study.

Authors:  Norah A Burchardt; Amy L Shafrir; Rudolf Kaaks; Shelley S Tworoger; Renée T Fortner
Journal:  Eur J Epidemiol       Date:  2020-12-17       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.